Skip to main content
. 2018 Aug 29;6(3):95. doi: 10.3390/pharmacy6030095

Table 3.

The Cochrane Risk of Bias Assessment.

Author (Year) Selection Bias Performance Bias Detection Bias Attrition Bias Reporting Bias Other Bias
Random Sequence Generation Allocation Concealment Blinding of Participants and Personnel Blinding of Outcome Assessment Incomplete Outcome Data Selective Reporting
Chibnall et al. (2005) [29] Unclear Unclear Low Low Low, 2 of 25 participants did not complete the RCT Low Unclear, very small sample size, 1 care home, support from the manufacturer of the medicine investigated.
Baker et al. (2008) [15] High High High, no attempt to blind Unclear Unclear, no information Moderate, no information on adverse effects High
Morad et al. (2012) [30] Low Unclear High, no information High-patients and recovery staff were not blinded. Unclear, 6/34 and 9/34 were excluded for Protocol violations. High, per protocol not intention to treat analysis Unclear, very small sample size, single centre
Hajimaghsoudi et al. (2013) [31] Low Unclear, no information High, open label High, open label Unclear, no information Unclear, missing data due to patient non-compliance Unclear
Park et al. (2015) [32] Unclear Unclear High, open label Unclear Moderate, 10/80 participants lost in each arm. No reasons given. Low, all adverse events were reported Unclear